Shopping Cart
- Remove All
- Your shopping cart is currently empty
CDK5 inhibitor 20-223 (CP668863) is a potent CDK2/CDK5 inhibitor with IC50 values of 6.0 nm and 8.8 nM, respectively, with anti-Colorectal Cancer (CRC) potential, inhibiting cell migration and inducing cell cycle arrest in multiple CRC cell lines.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $95 | In Stock | |
50 mg | $789 | 6-8 weeks | |
100 mg | $1,180 | 6-8 weeks |
Description | CDK5 inhibitor 20-223 (CP668863) is a potent CDK2/CDK5 inhibitor with IC50 values of 6.0 nm and 8.8 nM, respectively, with anti-Colorectal Cancer (CRC) potential, inhibiting cell migration and inducing cell cycle arrest in multiple CRC cell lines. |
Targets&IC50 | CDK2/CDK5:362 nM |
In vitro | CDK5 inhibitor 20-223 inhibits CDK2/CDK5 (IC₅₀ ≈ 362 nM), causes cell cycle arrest, reduces RB and FAK phosphorylation, and blocks CRC cell migration. CRC cell lines SW620, DLD1, HT29, HCT116, FET, CBS, and GEO cells[1]. |
In vivo | In mice, CDK5 inhibitor 20-223 (8 mg/kg, 3 weeks) significantly reduced tumor growth without toxicity and lowered pFAK levels in tumors[1]. |
Alias | CP668863, CP 668863 |
Molecular Weight | 305.37 |
Formula | C19H19N3O |
Cas No. | 865317-30-2 |
Smiles | O=C(NC1=NNC(=C1)C2CCC2)CC=3C=CC=4C=CC=CC4C3 |
Storage | keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (261.98 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.